MECHI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.251
EU - Europa 1.033
AS - Asia 324
AF - Africa 11
SA - Sud America 1
Totale 2.620
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.249
RU - Federazione Russa 466
PL - Polonia 172
IT - Italia 138
IE - Irlanda 119
CN - Cina 87
SG - Singapore 77
SE - Svezia 68
HK - Hong Kong 56
JO - Giordania 48
IN - India 31
DE - Germania 13
GB - Regno Unito 13
SA - Arabia Saudita 12
CI - Costa d'Avorio 10
FI - Finlandia 9
FR - Francia 9
UA - Ucraina 7
BE - Belgio 6
CH - Svizzera 6
IR - Iran 5
GR - Grecia 3
KR - Corea 3
CA - Canada 2
IL - Israele 2
NL - Olanda 2
VN - Vietnam 2
AT - Austria 1
BR - Brasile 1
LT - Lituania 1
SC - Seychelles 1
TR - Turchia 1
Totale 2.620
Salva come PNG Salva come JPEG
Città #
Santa Clara 244
Warsaw 172
Chandler 132
Fairfield 120
Dublin 119
Ashburn 76
Singapore 62
Seattle 55
Beijing 46
Woodbridge 46
Houston 45
Ann Arbor 43
Cambridge 40
Wilmington 37
Hong Kong 34
Lawrence 34
Altamura 32
Milan 28
Florence 27
Princeton 27
Mumbai 26
Buffalo 22
Kent 21
Boston 19
Shanghai 19
New York 16
Moscow 14
Riyadh 12
Abidjan 10
Dearborn 10
San Diego 9
Jacksonville 7
Medford 7
Norwalk 7
Bern 6
Brussels 6
West Jordan 6
Forlì 4
Helsinki 3
Lappeenranta 3
London 3
Rome 3
Seoul 3
Thessaloniki 3
Bologna 2
Chennai 2
Corsico 2
Dong Ket 2
Falls Church 2
Forney 2
Genoa 2
Guangzhou 2
Hefei 2
Jinan 2
Kiryat Ono 2
Nanjing 2
Palermo 2
Pune 2
Redwood City 2
Romola 2
Salerno 2
San Giuliano Terme 2
Toronto 2
Yubileyny 2
Auburn Hills 1
Berlin 1
Bielefeld 1
Boardman 1
Bremen 1
Campi Bisenzio 1
Carate Brianza 1
Chengdu 1
Frankfurt am Main 1
Hanover 1
Hyderabad 1
Islington 1
Istanbul 1
Kunming 1
Los Angeles 1
Modena 1
Naaldwijk 1
Naples 1
Phoenix 1
Pontassieve 1
Redmond 1
Shenzhen 1
Southwark 1
São Paulo 1
Verona 1
Vienna 1
Vilnius 1
Wenzhou 1
Wuhan 1
Xi'an 1
Totale 1.728
Salva come PNG Salva come JPEG
Nome #
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 251
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 155
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis. 131
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. 128
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study 113
Clinical and genetic characteristics of late-onset Huntington's disease 111
Suicidal ideation in a European Huntington's disease population 109
Human fetal striatal transplantation in disease. First italian clinic trial at the University of Florence. Preliminare Report 104
Effect of disease-modifying treatments on antibody-mediated response to anti- COVID19 vaccination in people with multiple sclerosis 101
The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination 94
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. 93
Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis. 88
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. 87
K index improves MS diagnosis and supports the differential diagnosis between MS and MS-like syndromes. 85
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 80
Leptomeningeal enhancement analysis in diagnostic clinical setting 76
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis. 76
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation 75
Imaging perivenular distribution can differentiate MS from CNS vasculitis. 72
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 72
CNS inflammation during relapsing remitting multiple sclerosis (RRMS): a molecular and cellular analysis of ex vivo CSF T lymphocyte expansions 68
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments 68
Brain atrophy evaluation in multiple sclerosis: change over time of corpus callosum area is more sensitive and reproducible than whole brain volume 67
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments 65
Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions 63
Soluble factor profile in Natalizumab treated MS patients: increased Th1 promoting factors and sHLAg 63
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: a population-based study on Tuscan residents 63
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis. 62
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience 57
Totale 2.677
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.411
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020249 0 0 0 0 38 27 42 33 25 47 29 8
2020/2021196 11 18 4 25 38 26 8 14 17 18 9 8
2021/2022176 4 15 11 10 0 10 7 21 9 9 28 52
2022/2023561 40 89 39 23 37 106 69 29 102 0 18 9
2023/2024284 11 32 31 18 22 27 13 45 4 32 30 19
2024/2025947 62 169 113 282 321 0 0 0 0 0 0 0
Totale 2.677